Literature DB >> 1114414

Antibiotic peritoneal lavage in severe peritonitis. A preliminary assessment.

J A Hunt, M E Rivlin, H J Clarebout.   

Abstract

A method of intra- and postoperative antibiotic peritoneal lavage, using 0.015% gentamicin in dialysis solution, has been assessed for the treatment of life-threatening peritonitis. It is believed to be the first time that the use of gentamicin for this purpose has been recorded, and the first time that antibiotic peritoneal lavage has been used for the treatment of a series of patients with peritonitis of gynaecological or obstetrical origin. At Baragwanath Hosital, gynaecological patients with life-threatening purulent peritonitis arising from septic abortions, tubal sepsis (ruptured pyosalpinx) or postoperative causes, were studied. Thirty-eight such patients undergoing standard operative treatment had a mortality of 47.4%, which is in accordance with world figures for serious peritonitis. In 38 patients, after the addition of antibiotic peritoneal lavage, mortality was halved to 2397%, with minimal morbidity. The procedure used has been fully described, and is recommended for wider trial in patients with life-threatening peritonitis or peritoneal soiling.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1114414

Source DB:  PubMed          Journal:  S Afr Med J


  4 in total

1.  The management of septic abortion in an intensive care unit.

Authors:  R D Cane; M Rivlin; N Buchanan
Journal:  Eur J Intensive Care Med       Date:  1976-11

2.  [Attempt at classification in patients with peritonitis--evaluation of 53 patients].

Authors:  G Hünefeld; N Friedel; R Pichlmayr
Journal:  Langenbecks Arch Chir       Date:  1986

3.  Acute renal failure following blunt civilian trauma.

Authors:  A J Matas; W D Payne; R L Simmons; T J Buselmeier; C M Kjellstrand
Journal:  Ann Surg       Date:  1977-03       Impact factor: 12.969

4.  Irrigation of abdomen with imipenem solution decreases surgical site infections in patients with perforated appendicitis: a randomized clinical trial.

Authors:  Mohammad Ali Hesami; Hamid Alipour; Hamed Nikoupour Daylami; Bijan Alipour; Shahrzad Bazargan-Hejazi; Alireza Ahmadi
Journal:  Iran Red Crescent Med J       Date:  2014-04-05       Impact factor: 0.611

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.